- Home
- ARGX vs AME Comparison
ARGX vs AME Comparison
Compare ARGX & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- AME
- Stock Information
- Founded
- ARGX 2008
- AME 1930
- Country
- ARGX Netherlands
- AME United States
- Employees
- ARGX N/A
- AME N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- AME Industrial Machinery/Components
- Sector
- ARGX Health Care
- AME Industrials
- Exchange
- ARGX Nasdaq
- AME Nasdaq
- Market Cap
- ARGX 40.4B
- AME 36.3B
- IPO Year
- ARGX 2017
- AME N/A
- Fundamental
- Price
- ARGX $596.20
- AME $157.81
- Analyst Decision
- ARGX Strong Buy
- AME Buy
- Analyst Count
- ARGX 20
- AME 9
- Target Price
- ARGX $699.56
- AME $202.25
- AVG Volume (30 Days)
- ARGX 465.0K
- AME 1.7M
- Earning Date
- ARGX 05-08-2025
- AME 05-01-2025
- Dividend Yield
- ARGX N/A
- AME 0.79%
- EPS Growth
- ARGX N/A
- AME 4.59
- EPS
- ARGX 12.78
- AME 5.93
- Revenue
- ARGX $2,248,205,000.00
- AME $6,941,180,000.00
- Revenue This Year
- ARGX $57.86
- AME $3.64
- Revenue Next Year
- ARGX $31.90
- AME $5.85
- P/E Ratio
- ARGX $43.64
- AME $26.61
- Revenue Growth
- ARGX 77.22
- AME 5.22
- 52 Week Low
- ARGX $352.77
- AME $145.02
- 52 Week High
- ARGX $678.21
- AME $198.33
- Technical
- Relative Strength Index (RSI)
- ARGX 51.80
- AME 37.47
- Support Level
- ARGX $583.00
- AME $148.30
- Resistance Level
- ARGX $610.06
- AME $162.77
- Average True Range (ATR)
- ARGX 24.42
- AME 6.01
- MACD
- ARGX 4.74
- AME 0.06
- Stochastic Oscillator
- ARGX 84.66
- AME 45.58
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About AME AMETEK Inc.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.